DSM-5 and ICD-10: Implications for the Assessment/Evaluation and Treatment for Substance-Related and Co-Occurring Disorders | Supported by AdCare

Date: 8.28.15 4:30pm &ndash; 5:30pm
Venue: <a href="https://www.mainebehavioralhealthworkforce.org/training/venues/augusta-me/"> Augusta, ME
Categories: <a href="https://www.mainebehavioralhealthworkforce.org/training/category/samhs/" rel="tag">SAMHS , <a href="https://www.mainebehavioralhealthworkforce.org/training/category/treatment/" rel="tag">Treatment

This session will focus on the DSM-5 changes related to the previous DSM-IV-TR, as well as the upcoming use of the ICD-10-CM on Oct. 1.